Consensus guidelines for the diagnosis and treatment of multiple sclerosis
| Autor: | S. Hashem, N Abouzeid, Maurice Dahdaleh, Jihad Inshasi, K ElKallab, Raed Alroughani, Saeed Bohlega, Taoufik Alsaadi, T Tawfeek, Samia J. Khoury, Mohammed Aljumah, Magd Zakaria, Bassem Yamout, I. Alsharoqi |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
medicine.medical_specialty
Pathology Multiple Sclerosis Optic Neuritis MEDLINE Antibodies Monoclonal Humanized Spinal Cord Diseases Middle East Natalizumab Sphingosine Optic Nerve Diseases medicine Humans Intensive care medicine business.industry Fingolimod Hydrochloride Multiple sclerosis Interferon beta-1b Interferon beta-1a McDonald criteria General Medicine Interferon-beta Myelitis medicine.disease Propylene Glycols business Immunosuppressive Agents medicine.drug |
| Zdroj: | Current medical research and opinion. 29(6) |
| ISSN: | 1473-4877 |
| Popis: | The diagnosis of multiple sclerosis (MS) is dependent on the presence of clinical and paraclinical evidence demonstrating dissemination of central nervous system lesions in both space and time, as well as the exclusion of other disorders. Diagnostic criteria were originally promulgated in 1965 by the Schumacher committee and modified subsequently by the Poser committee to include paraclinical evidence. The most recent criteria are the 2010 modifications of the 2001 McDonald criteria, which are focused on making an earlier diagnosis of MS. This article provides guidelines, derived from clinical experience as well as evidence-based medicine, for the diagnosis and management of MS with special emphasis on practices in the Middle East. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|